Cloud Banner

Product Launch (Blog)

Sep, 08 2023

RNA Interference (RNAi) Therapeutics: Silencing Genes for Disease Treatment

Antisense and RNA interference (RNAi) therapeutics are ground-breaking approaches that harness genetic mechanisms to treat diseases. Antisense targets specific genes, inhibiting their expression, while RNAi uses small RNA molecules to silence target genes. Both methods offer highly precise and personalized treatments, potentially addressing various diseases such as genetic disorders and cancer. Their ability to modify gene activity at the molecular level holds promise for tailored medical interventions, with potential applications ranging from rare diseases to broader healthcare challenges.

According to Data Bridge Market Research, the Global Antisense and RNAi Therapeutics Treatment Market is expected to grow with a CAGR of 13.00% in the forecast period of 2022 to 2029.

“Integration and acceptance of novel technologies boost the market’s growth”

The growth of the antisense and RNAi therapeutics treatment market is propelled by the integration and acceptance of novel technologies in medical treatment. These advancements enable precise targeting of genetic elements responsible for diseases, leading to more effective therapies. The adoption of these technologies enhances treatment outcomes, reduces side effects, and expands the range of treatable conditions. As a result, the antisense and RNAi therapeutics market experiences accelerated growth due to the improved efficacy and broader applicability of these innovative treatment approaches.

What restraints the growth of the global antisense and RNAi therapeutics treatment market?

“Risk of triggering unwanted immunological responses restraints the market’s growth”

The development of antisense and RNAi therapeutics is constrained by the risk of eliciting undesired immune responses. When foreign nucleic acids are introduced into the body, they can provoke immune reactions, compromising treatment safety and efficacy. Immune responses might hinder the therapeutic's intended effects or, in severe cases, result in adverse effects. Researchers and developers in this field are actively working to mitigate these challenges through improved delivery methods and enhanced nucleic acid design to ensure the safe and effective use of antisense and RNAi treatments in various diseases.

Segmentation: Global Antisense and RNAi Therapeutics Treatment Market

The global antisense and RNAi therapeutics treatment market is segmented on the basis of indication, technology, route of administration, end-users, and distribution channel. 

  • On the basis of indication, the antisense and RNAi therapeutics market is segmented into oncology, cardiovascular diseases (CVDs), respiratory disorders, neurological disorders, infectious diseases, and others.
  • On the basis of technology, the antisense and RNAi therapeutics market is segmented into RNA Interference, Antisense RNA. The RNA interference segment is further categorized into small interfering RNA (siRNA) and microRNAs (miRNAs).
  • On the basis of route of administration, the antisense and RNAi therapeutics market is segmented into pulmonary delivery, intravenous injections, intra-dermal, intraperitoneal, topical, and others.
  • On the basis of end-users, the antisense and RNAi therapeutics treatment market is segmented into clinic, hospital, and others.
  • On the basis of distribution channel, the antisense and RNAi therapeutics treatment market is segmented into hospital pharmacy, retail pharmacy, and online pharmacy.

Regional Insights: North America is expected to account for the largest market share

North America is expected to account for the largest market share due to a surge in genetic disorders and FDA-approved drugs. The region anticipates substantial expansion due to rising instances of chronic diseases, signifying an escalating demand for advanced treatments and therapies to address the increasing healthcare challenges associated with these conditions.

Europe is expected to have bright growth prospects in the coming years due to rising prevalence of chronic diseases is attributed to factors like aging populations, unhealthy lifestyles, and improved disease detection. Chronic conditions, such as diabetes, heart disease, and cancer, pose substantial health and economic burdens.

 Asia-Pacific is expected to have significant growth as market leaders are actively concentrating on enlarging their footprint in this region. This strategic emphasis reflects their intent to tap into its growth potential and solidify their dominance. As a result, the region has become a focal point for industry expansion and heightened competition among key players.

To know more about the study visit, https://www.databridgemarketresearch.com/reports/global-antisense-and-rnai-therapeutics-market

The Prominent Key Players Operating in the Global Antisense and RNAi Therapeutics Treatment Market Include:

  • Astellas Pharma Inc (U.S.)
  • Quark (U.S.)
  • Alnylam Pharmaceuticals, Inc (U.S.)
  • Dicerna Pharmaceuticals (U.S.)
  • Tekmira Pharmaceuticals (U.S.)
  • Benitec Biopharma (U.S.)
  • Sanofi (U.S.)
  • Ionis Pharmaceuticals (U.S.)
  • Silence Therapeutics (U.K.)
  • Cenix BioScience (U.K.)
  • Sirnaomics (U.S.)
  • CureVac AG (U.S.)
  • BioNTech SE (Germany)
  • Arrowhead Pharmaceuticals, Inc (U.S.)
  • Arbutus Biopharma (Canada)
  • Marina Biotech, Inc (U.S.)

Above are the key players covered in the report, to know about more and exhaustive list of global antisense and RNAi therapeutics treatment market companies contact, https://www.databridgemarketresearch.com/contact

Research Methodology: Global Antisense and RNAi Therapeutics Treatment Market

Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.


Client Testimonials